Cannabinoids in Metabolic Syndrome and Cardiac Fibrosis

Carmen Navarrete,Adela Garcia-Martin,Jim DeMesa,Eduardo Muñoz
DOI: https://doi.org/10.1007/s11906-020-01112-7
2020-10-21
Current Hypertension Reports
Abstract:This article provides a concise overview of how cannabinoids and the endocannabinoid system (ECS) have significant implications for the prevention and treatment of metabolic syndrome (MetS) and for the treatment of cardiovascular disorders, including cardiac fibrosis.
peripheral vascular disease
What problem does this paper attempt to address?